The global Lennox-Gastaut syndrome therapeutics market is witnessing a period of significant expansion. This phenomenon can be attributed to several factors, including an rising prevalence of Lennox-Gastaut syndrome globally and advancements in treatment strategies. The market is driven by a growing requirement for effective therapies to control th